Cited by 1,008RNA and protein synthesis mechanismsAntibiotic Resistance in BacteriaBacterial Genetics and Biotechnology

Erythromycin resistance by ribosome modification

Open access
Weisblum, B·1995·Antimicrobial Agents and Chemotherapy

Abstract

Free access1 March 1995 Share on Erythromycin resistance by ribosome modificationAuthor: B WeisblumAuthors Info & AffiliationsDOI: https://doi.org/10.1128/aac.39.3.577 PDF/EPUB

Integrity signals

Registry

Crossref · 10.1128/aac.39.3.577

Cites

139 of 139 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Bourse R., Monnier J. Effet de l'érythromycine sur la croissae de Staph. aureus "resistant dissocié" en bactériostase par un autre macrolide ou un antibiotique apparenté. Ann Inst Pasteur (Paris) 1967 Jul;113(1):67–79. [PubMed] [Google Scholar]
  2. CHABBERT Y. Antagonisme in vitro entre l'érythromycine et la spiramycine. Ann Inst Pasteur (Paris) 1956 Jun;90(6):787–790. [PubMed] [Google Scholar]

Cited by

Sorted by citations

Authors
Weisblum, B.
Affiliations
University of Wisconsin System (US)
Corresponding author
Weisblum, B
Venue
Antimicrobial Agents and Chemotherapy
Published
1995-03
Volume
39
Issue
3
Pages
577-585
ISSN
  • 0066-4804 (ISSN-L)
  • 1098-6596
OpenAlex
W2135493947
Cited by
1,008
References
139
Citations by year
2026: 21 · 2025: 27 · 2024: 19 · 2023: 28 · 2022: 30 · 2021: 29 · 2020: 34 · 2019: 27 · 2018: 30 · 2017: 32 · 2016: 36 · 2015: 46 · 2014: 32 · 2013: 27 · 2012: 22
FWCI
8.80
Type
journal article
Language
en
Open access
Locations
  • Antimicrobial Agents and Chemotherapy (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01ai018283-15)
  • National Institute of Allergy and Infectious Diseases (AI-18283)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Antibiotic Resistance in Bacteria
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
Keywords
erythromycin resistance, ribosome modification, ribosomal RNA modification, macrolide antibiotics, antibiotic resistance mechanisms
MeSH terms
Base Sequence, Drug Resistance, Microbial, Erythromycin, Molecular Sequence Data, Ribosomes, RNA, Ribosomal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review